KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Change in Taxes: 2015-2024

Historic Change in Taxes for Travere Therapeutics (TVTX) over the last 10 years, with Dec 2024 value amounting to $41,000.

  • Travere Therapeutics' Change in Taxes rose 76.34% to -$22,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $154,000, marking a year-over-year increase of 100.90%. This contributed to the annual value of $41,000 for FY2024, which is 17.14% up from last year.
  • Per Travere Therapeutics' latest filing, its Change in Taxes stood at $41,000 for FY2024, which was up 17.14% from $35,000 recorded in FY2023.
  • Over the past 5 years, Travere Therapeutics' Change in Taxes peaked at $15.7 million during FY2020, and registered a low of -$17.1 million during FY2021.
  • In the last 3 years, Travere Therapeutics' Change in Taxes had a median value of $41,000 in 2024 and averaged $150,000.
  • Per our database at Business Quant, Travere Therapeutics' Change in Taxes soared by 2,937.12% in 2020 and then crashed by 208.59% in 2021.
  • Over the past 5 years, Travere Therapeutics' Change in Taxes (Yearly) stood at $15.7 million in 2020, then tumbled by 208.59% to -$17.1 million in 2021, then skyrocketed by 102.19% to $374,000 in 2022, then tumbled by 90.64% to $35,000 in 2023, then climbed by 17.14% to $41,000 in 2024.